Localization of anti-osteogenic sarcoma monoclonal antibody 791T/36 in a primary human osteogenic sarcoma and its subsequent xenograft in immunodeprived mice
- PMID: 3856475
- PMCID: PMC11039251
- DOI: 10.1007/BF00199306
Localization of anti-osteogenic sarcoma monoclonal antibody 791T/36 in a primary human osteogenic sarcoma and its subsequent xenograft in immunodeprived mice
Abstract
A primary human osteogenic sarcoma was visualized in situ by external gamma-camera imaging following administration of 131I-labelled anti-osteogenic sarcoma monoclonal antibody 791T/36. A xenograft of the tumour established in immunodeprived mice also showed localization of 131I-791T/36 determined by both gamma-camera imaging and organ distribution studies. Radiolabelled normal immunoglobulin showed no tumour localization. Expression of the 791T/36-defined antigen on xenografted tissue was further confirmed by reaction of its in vitro-cultured cells with fluorescein-labelled 791T/36 antibody.
Similar articles
-
Interferon-alpha conjugation to human osteogenic sarcoma monoclonal antibody 791T/36.Cancer Immunol Immunother. 1983;15(3):210-6. doi: 10.1007/BF00199167. Cancer Immunol Immunother. 1983. PMID: 6577942 Free PMC article.
-
Monoclonal antibodies for radioimmunodetection of tumours and for targeting.Bull Cancer. 1983;70(2):132-6. Bull Cancer. 1983. PMID: 6575842
-
Antitumor monoclonal antibodies for radioimmunodetection of tumors and drug targeting.Cancer Metastasis Rev. 1983;2(1):89-106. doi: 10.1007/BF00046907. Cancer Metastasis Rev. 1983. PMID: 6352009 Review.
-
Differentiation between monoclonal antibody-defined antigens on a human osteogenic sarcoma cell line (791T) and tumor-localizing properties of the anti-791T/36 antibody.Braz J Med Biol Res. 1986;19(2):257-69. Braz J Med Biol Res. 1986. PMID: 3470084
-
Complement-dependent cytotoxicity of anti-human osteogenic sarcoma monoclonal antibodies.Br J Cancer. 1982 Oct;46(4):601-10. doi: 10.1038/bjc.1982.244. Br J Cancer. 1982. PMID: 6958308 Free PMC article.
Cited by
-
Complement decay accelerating factor (DAF)/CD55 in cancer.Cancer Immunol Immunother. 2006 Aug;55(8):987-95. doi: 10.1007/s00262-006-0136-8. Epub 2006 Feb 17. Cancer Immunol Immunother. 2006. PMID: 16485129 Free PMC article.
References
-
- Berche C, Mach J-P, Lumbroso J-D, Langlais C, Aubry F, Buchegger F, Carrel S, Rougier P, Parmentier C, Tubiana M. Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: First clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen. Br Med J. 1982;285:1447. - PMC - PubMed
-
- Colcher D, Zalutsky M, Kaplan W, Kufe D, Austin F, Schlom J. Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody. Cancer Res. 1983;43:736. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources